Putting Patients First Blog

JANUARY 27, 2025

Timely implementation is particularly critical for beneficiaries requiring immediate mental health or substance use treatment, where delays can lead to worsening health outcomes, increased hospitalization rates, and preventable mortality. 38 Furthermore, CMS should include manufacturer rebates in the definition of “negotiated price.”

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. However, low-cost generic and biosimilar manufacturers are likely to be particularly exposed to these economic pressures. The entire pharma industry will be affected by the fallout.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 64

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. However, low-cost generic and biosimilar manufacturers are likely to be particularly exposed to these economic pressures. The entire pharma industry will be affected by the fallout.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52